Bio

Scott joined Covington Associates as a Managing Director in 2013. He has over twenty-five years of M&A, corporate development, principal investing, and corporate strategy experience, primarily in the healthcare and life sciences sectors. At Covington, Scott focuses on Pharmaceutical Services & Technology, working extensively with CROs, CDMOs, and related technology businesses, as well as Healthcare IT. Prior to joining Covington in 2013, Scott was a co-founder of Centerstone Partners, a life sciences investment and advisory firm. At Centerstone, Scott helped build and finance several life sciences companies as a founder, investor, operator, and advisor, including Amerigen Pharmaceuticals, Theorem Clinical Research, and Cuda Pharmaceuticals, among others. Scott has served on the Boards of and advised numerous private companies, and his experience spans both domestic and emerging markets. Previously, Scott was the Director of Corporate Development at Fisher Scientific International, where he led mergers and acquisitions for Fisher’s healthcare and diagnostics businesses. Prior to Fisher Scientific, Scott worked at Bain & Company, focusing on growth strategies and private equity engagements. Scott began his career at First Union Capital Partners, where he executed middle-market leveraged buyout and growth equity investments. Scott holds an MBA from Harvard Business School and a BA in Economics from Duke University. In addition to his role with Covington, Scott also serves as a Managing Director at Pleasant Bay Capital Partners, a lower middle market private equity firm co-founded with Covington in 2012. Scott lives in Hingham with his wife and two children. He is an avid world traveler and college basketball fan.